Brief: Inify Laboratories Q1 Sales Up At SEK 6.3 Mln
29/04/2026 07:21
April 29 (Reuters) - INIFY Laboratories AB INIFY.OL: Q1 SALES SEK 6.3 MILLION VERSUS SEK 5.2 MILLION YEAR AGO Q1 EBITDA SEK -18.1 MILLION VERSUS SEK -14.5 MILLION YEAR AGO WE HAVE CLEAR FOCUS ON CONTINUING TO GROW OUR BUSINESS IN SWEDEN WHILE SIMULTANEOUSLY PENETRATING MARKET IN THE UK Source text: ID:nObitzs2Za Further company coverage: INIFY.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on INIFY Laboratories AB
See all newsBrief: Inify Laboratories Signs Deal With University Hospitals Plymouth NHS Trust
Brief: Inify Laboratories Gets CQC Registration, Is Fully Operational In UK
Brief: Inify Laboratories Q1 Sales Up At SEK 6.3 Mln
Brief: Inify Laboratories Signs Agreement With Region Jämtland Härjedalen
Brief: Inify Laboratories Has Signed An Agreement With Region Jamtland Harjedalen For Prostate Cancer Diagnostics